Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Preventing potential patient harm through clinical content interventions during oncology clinical trial implementation.

Loo VC, Kim S, Johnson LM, et al. Preventing potential patient harm through clinical content interventions during oncology clinical trial implementation. J Patient Saf. 2023;19(7):460-464. doi:10.1097/pts.0000000000001154.

Save
Print
September 20, 2023
Loo VC, Kim S, Johnson LM, et al. J Patient Saf. 2023;19(7):460-464.
View more articles from the same authors.

Ensuring the safety of clinical trial participants is paramount to successful, meaningful clinical research. In this study, researchers examined 585 clinical trial documents and found that 17% included potential patient safety interventions (e.g., resolving medication dosing discrepancies). The authors suggest that clinical specialists’ review of study protocol documents could enhance patient safety during clinical trial conduct.

Save
Print
Cite
Citation

Loo VC, Kim S, Johnson LM, et al. Preventing potential patient harm through clinical content interventions during oncology clinical trial implementation. J Patient Saf. 2023;19(7):460-464. doi:10.1097/pts.0000000000001154.

Related Resources From the Same Author(s)